Pandemic propels global effort to study rare vaccine side effects
"You really need global data in order to understand" rare vaccine side effects, says Gregory Poland, a vaccinologist at the Mayo Clinic.
In this article Pandemic propels global effort to study rare vaccine side effects published in Science, we learn the origins of the GVDN, hear of the 'gnarly' process of pulling a venture of this magnitude together from around the globe, and are updated on where the GVDN is at today with scientists in more than 20 countries, on every continent save Antarctica, gathering data from more than 250 million people for the largest ever vaccine safety project.